Journal of Clinical Pediatrics ›› 2026, Vol. 44 ›› Issue (5): 381-393.doi: 10.12372/jcp.2026.25e1596

• Standard · Protocol · Guideline •     Next Articles

Expert consensus on non-pharmacological interventions for atopic dermatitis in children

Professional Committee of Child Allergology, China Maternal and Child Health Association; Dermatology and Venereology Group of Pediatric Branch Society, Chinese Medical Association: Editorial Board of the Journal of Clinical Pediatrics   

  • Received:2025-12-16 Accepted:2026-04-02 Published:2026-05-15 Online:2026-05-08

Abstract:

Atopic dermatitis (AD), a chronic and recurrent inflammatory skin disorder, has witnessed a sustained global and domestic upward trend in incidence since the 21st century, emerging as a critical public health concern. The comprehensive management framework for AD encompasses two core pillars: pharmacotherapy and non-pharmacological interventions. Despite the expanding armamentarium of AD pharmacotherapies in recent years, the intricate pathogenesis and marked clinical heterogeneity of AD render monotherapy insufficient for optimal disease control. Non-pharmacological interventions thus remain an indispensable cornerstone in AD prevention and management. However, existing domestic and international AD treatment consensus and guidelines are predominantly structured around pharmacotherapy, with a notable paucity of systematic attention and integration of non-pharmacological strategies. Against this backdrop, the Children’s Allergy Committee of the China Maternal and Child Health Association, the Dermatology and Venereology Group of Pediatric Branch Society, Chinese Mechical Association and Editorial Board of the Journal of Clinical Pediatrics convened 33 dermatology experts from 30 medical institutions to formulate this consensus, drawing on the latest domestic and international research advances and clinical practice experience. This consensus systematically delineates non-pharmacological management strategies for AD, with core recommendations including avoidance of triggering factors, standardized skin care to maintain skin barrier homeostasis, and implementation of health education and psychological support. It emphasizes the pivotal role of non-pharmacological interventions as foundational measures in AD management, aiming to reduce disease recurrence and enhance the quality of life of affected children. Additionally, it clarifies the applicable scenarios and key implementation points for each measure, providing systematic and practical guidance for clinicians, caregivers of affected children, and health managers.

Key words: atopic dermatitis, non-pharmacological intervention, skin care, skin barrier homeostasis, child

CLC Number: 

  • R72